Cellular and Non-Cellular Liver Assist Devices in Management of Acute and Acute on Chronic Liver Failure
Author:
- 31 October 2020
- book chapter
- Published by Springer Nature
- p. 319-354
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Similarities, Differences, and Potential Synergies in the Mechanism of Action of Albumin Dialysis Using the MARS Albumin Dialysis Device and the CytoSorb Hemoperfusion Device in the Treatment of Liver FailureBlood Purification, 2020
- Opal, but not MARS improves patients albumin binding function measured by Electron Spin Resonance (ESR) in a prospective multicenter trialJournal of Hepatology, 2018
- Targeting Albumin Binding Function as a Therapy Goal in Liver Failure: Development of a Novel Adsorbent for Albumin DialysisTherapeutic Apheresis and Dialysis, 2017
- Albumin handling in different hemodialysis modalitiesNephrology Dialysis Transplantation, 2017
- First clinical experience in 14 patients treated with ADVOS: a study on feasibility, safety and efficacy of a new type of albumin dialysisBMC Gastroenterology, 2017
- Industrial stabilizers caprylate and N -acetyltryptophanate reduce the efficacy of albumin in liver patientsLiver Transplantation, 2011
- Improvement of Impaired Albumin Binding Capacity in Acute-on-Chronic Liver Failure by Albumin DialysisLiver Transplantation, 2008
- 237 FATTY ACID DEPLETED ALBUMIN CAN IMPROVE EFFECT OF ALBUMIN DIALYSIS IN LIVER SUPPORTJournal of Hepatology, 2008
- Albumin-binding function is reduced in patients with decompensated cirrhosis and correlates inversely with severity of liver disease assessed by model for end-stage liver diseaseEuropean Journal of Gastroenterology & Hepatology, 2007
- Dialysis against a Recycled Albumin Solution Enables the Removal of Albumin‐Bound ToxinsArtificial Organs, 1993